HLA typing
FDA Approves Thermo Fisher Scientific HLA Typing Kit as CDx for Adaptimmune T-Cell Receptor Therapy
Adaptimmune's therapy is intended to treat patients with unresectable or metastatic synovial sarcoma who have received prior chemotherapy.
Lung Cancer Study Highlights Genetic Variants Involved in Immunosurveillance
Researchers used large-scale population data to link lower-than-usual lung cancer risk to increased heterozygosity in the human leukocyte antigen class II region.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
Omixon and GenDx have independently developed nanopore-based HLA typing kits that are currently for research use only but eventually aimed for diagnostic use.
COVID-19 Protection Provided by HLA Genetic Variant, Study Suggests
Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.